Flow cytometry:MPAL: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
|} | |} | ||
MPAL is uncommon (2-3% of acute leukaemia). Flow cytometry provides initial evidence of MPAL. However conclusions may subsequently be modified (e.g. by results of immunohistochemistry, cytogenetics, or genetics). It is important that the provisional nature of flow cytometry assignment of MPAL is acknowledged.</b> | |||
MPAL is uncommon (2-3% of acute leukaemia). Flow cytometry provides initial evidence of MPAL. However conclusions may subsequently be modified (e.g. by results of immunohistochemistry, cytogenetics, or genetics). It is important that the provisional nature of flow cytometry assignment of MPAL is acknowledged. | |||
'''Types and frequency of MPAL types''' | '''Types and frequency of MPAL types''' | ||
| Line 22: | Line 20: | ||
(3) MPAL with combinations: MPAL B/T (rare) or B/T/M (very rare)</br> | (3) MPAL with combinations: MPAL B/T (rare) or B/T/M (very rare)</br> | ||
(4) Following further analysis cases may be assigned additionally as:</br> | (4) Following further analysis cases may be assigned additionally as:</br> | ||
<span style="font-size:90%;">MPAL with t(9;22) (q34.1;q11.2); BCR-ABL1; </span></br> | :<span style="font-size:90%;">MPAL with t(9;22) (q34.1;q11.2); BCR-ABL1; </span></br> | ||
<span style="font-size:90%;">MPAL with t(v;11q23.3); with KMT2A re-arrangement</span></br> | :<span style="font-size:90%;">MPAL with t(v;11q23.3); with KMT2A re-arrangement</span></br> | ||
---- | ---- | ||
Revision as of 10:56, 5 January 2024
| Mixed Phenotype Acute Leukaemia (MPAL) |
MPAL is uncommon (2-3% of acute leukaemia). Flow cytometry provides initial evidence of MPAL. However conclusions may subsequently be modified (e.g. by results of immunohistochemistry, cytogenetics, or genetics). It is important that the provisional nature of flow cytometry assignment of MPAL is acknowledged.
Types and frequency of MPAL types
(1) MPAL with features of Myeloid and B-lineage (MPAL M/B) (>50% cases)
(2) MPAL with features of Myeloid and T-lineage (MPAL M/T) (>33% cases)
(3) MPAL with combinations: MPAL B/T (rare) or B/T/M (very rare)
(4) Following further analysis cases may be assigned additionally as:
- MPAL with t(9;22) (q34.1;q11.2); BCR-ABL1;
- MPAL with t(v;11q23.3); with KMT2A re-arrangement
.
| To diagnose MPAL, the leukaemia should meet at least two of the three criteria below | |
|---|---|
| Criteria to assign myeloid lineage | |
| Click here to review criteria for myeloid lineage assignment | |
| Criteria to assign B-lymphoid lineage | |
| Click here to review criteria for B-lymphoid lineage assignment | |
| Criteria to assign T-lymphoid lineage | |
| Click here to review criteria for T-lymphoid lineage assignment |